Chinese biopharmaceutical firm Qyuns Therapeutics has raised several hundred millions of yuan in a series B round of financing led by Hongtai Capital, a venture capital firm co-established by the founder of Chinese education giant New Oriental Education. Chinese investment companies Triwise Capital and Hefu Ruitai also participated in this round, according to a statement […] Hongtai Capital Backs Chinese Biopharma Firm Qyuns Therapeutics In Series B Round comes originally from China Money Network. All Rights Reserved.